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Highlights 
-  Postoperative aspiration pneumonia is a rare complication, however,  remains a severe 
disease with a significant mortality of 27% in this series. 
- Increasing age, the need for intraoperative blood component transfusion and bilateral 
pulmonary infiltrates are independent risk factors for fatal outcome after aspiration pneumonia. 
- The identification of those patients at increased risk for death after aspiration may help to 
further improve patients outcome. 
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Abstract 
 
Methods: Aspiration pneumonia in hospitalized surgical patients has been associated with a 
mortality of approximately 30%. The aim of this study was to assess pre-, intra- and 
postoperative risk factors for mortality in patients suffering aspiration pneumonia after 
abdominal surgery. Retrospective study from 01/2006-12/2012 of patients with clinically and 
radiologically confirmed aspiration pneumonia after abdominal surgery.  
Results: A total of 70 patients undergoing abdominal surgery and postoperative aspiration 
pneumonia were identified. There were 53 (76%) male patients, the mean age was 71±12 years 
and the mean ASA score was 3±1. The surgical procedures included 32 colorectal or small 
bowel resections, 10 partial liver resections, 9 gastric surgeries, 8 esophageal resections, 5 
pancreatic surgeries, and 6 hernia repairs. Aspiration pneumonia occurred at mean 
postoperative day 7±10. Overall, 53% (n=37) of patients required re-intubation, with 4±5 days of 
additional mechanical ventilation. Mean hospital and ICU length of stay was 32±25 days and 
6±9 days, respectively. Overall mortality was 27% (n=19). Forward logistic regression revealed 
older age [OR 7.41 (95% CI: 1.29-42.62)], bilateral aspiration pneumonia [OR 7.39 (95% CI: 
1.86-29.29)] and intraoperative requirement of blood component transfusion [OR 5.09 (95% CI: 
1.34-19.38)] as independent risk factors for mortality (overall R2=0.336).  
Conclusion: Postoperative aspiration pneumonia remains a severe complication with significant 
mortality. Increasing age, the need for intraoperative blood component transfusion and bilateral 
pulmonary infiltrates are independent risk factors for fatal outcome after aspiration pneumonia. 
Therefore, these patients suffering aspiration pneumonia require special attention and increased 
monitoring. 
 
Keywords: Aspiration pneumonia, abdominal surgery, complication, critical care. 
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1. Introduction 
Aspiration pneumonia is a precarious and well-known complication of hospitalized patients, with 
a high mortality rate of around 30%[1], or historically of up to 90%[2]. Moreover, it may cause re-
admission to the intensive care unit as well as prolonged hospital length of stay, with significant 
increases in the costs of hospital care[3].  
Surgical patients requiring general anesthesia and abdominal surgery with potential consequent 
bowel paralysis have an increased risk of pulmonary aspiration and aspiration pneumonia. 
Furthermore, patients with altered levels of consciousness, neurological disorders, history of 
pulmonary disease, older age and gastroesophageal reflux disease are at risk of aspiration 
pneumonia[4, 5]. The 30° elevation of the upper body has been shown to reduce the risk of 
aspiration pneumonia in the intensive care unit (ICU)[6]. Routine nasogastric decompression 
tubes[7] or percutaneous feeding tubes instead of nasogastric feeding tubes have not been 
shown to reduce the risk of pulmonary aspiration[8]. 
While guidelines and recommendations to identify patients at risk of aspiration pneumonia have 
been studied and published, risk factors for lethal outcome after diagnosed aspiration 
pneumonia have not been studied so far. However, identification of risk factors for fatal outcome 
may help to improve the management of this severe complication.  
In this retrospective study, we opted to identify independent risk factors for mortality in patients 
suffering postoperative aspiration pneumonia. Therefore, pre-, intra- and postoperative 
parameters were analyzed of patients undergoing major abdominal surgery with postoperatively 
confirmed aspiration pneumonia. The early identification of those patients at increased risk for 
death after aspiration may help to further improve patients outcome. 
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2. Materials and Methods  
A retrospective study of patients from 01/2006-12/2012 with clinically and radiologically 
confirmed aspiration pneumonia after abdominal surgery was performed at Bern University 
Hospital, which is a tertiary academic medical center in central Switzerland. All patients who 
undergo abdominal surgical procedures received antibiotic prophylaxis. Insertion of nasogastric 
tubes was at the discretion of the attending surgeon. At Bern University Hospital, protocoled 
measures to prevent pulmonary aspiration are in place through the pre-, intra-, and 
postoperative phases.  
Patients with aspiration pneumonia were identified through the institutional digital patients’ chard 
system, using the keywords “aspiration” AND/OR “pneumonia”. Subsequently, all patients were 
carefully reviewed by one investigator (GR). To reduce heterogeneity, patients who aspirated 
before or during the surgical procedure were excluded from the study. Aspiration pneumonia 
was diagnosed by witnessed aspiration and subsequent confirmation by a conventional X-ray or 
computed tomography (CT) scan of the chest. All X-rays and CT scans were reviewed by one 
independent attending radiologist (DO).  
Patient characteristics were collected using a computerized spreadsheet (Microsoft Access 
2003, Microsoft Corporation, Redmond, WA). The collected demographic and pre-operative 
variables were: age, gender, main diagnosis, as well as co-morbidities, prior surgical 
procedures (thoracic, cardiovascular, abdominal), preoperative insertion of nasogastric tube, 
smoking history, alcohol abuse, drugs administered preoperatively (proton pump inhibitors, 
antibiotics, sedatives, opiates, neuroleptic agents), chronic pulmonary disease, gastro-
esophageal reflux disease (GERD), and American Society of Anesthesiologists (ASA) physical 
status classification. Intraoperative variables collected included: type of surgery performed, 
ileostomy, colostomy, respiratory global insufficiency, amount of blood loss, operation time, 
transfusion of fresh frozen plasma (FFP), red blood cell (RBC) transfusion, and episodes of 
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intraoperative hypotension [mean arterial pressure (MAP)≤55mmHg]. Postoperative parameters 
collected included: postoperative day of pulmonary aspiration, days on intensive care unit (ICU), 
days on intermediate care (IMC), ICU readmission, length of mechanical ventilation, the need 
for re-intubation, nasogastric tube postoperatively, re-insertion of nasogastric tube, feeding 
jejunostomy, nausea, vomiting, first bowel movement, day of first mobilization, patient controlled 
analgesia, peridural analgesia, postoperative medication, and hospital length of stay (HLOS).  
 
  
2.1 Statistics 
Continuous and categorical variables are reported as mean ± standard deviation (SD), or 
median ± range and percentages. In order to identify risk factors for fatal outcome after 
aspiration pneumonia, all parameters were compared between the survivor and non-survivor 
group. Proportions and continuous variables were compared using the Fisher exact and the 
Mann-Whitney U test, respectively. Potential risk factors were identified using a p-value <0.2. 
Moreover, those variables of special interest were forced into the equation. Forward logistic 
regression analysis was used in order to identify independent risk factors for mortality.  
All statistical analyses were performed using the Statistical Package for Social Sciences (SPSS 
Windows©), version 21.0 (SPSS Inc., Chicago, IL). A p-value of <0.05 was considered 
statistically significant.  
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3. Results 
From 01/2006-12/2012, a total of 70 patients with aspiration pneumonia after abdominal surgery 
were detected and included in the study. There were 53 (76%) male patients, the mean age was 
71±12 years and the mean ASA score was 3±1. The following surgical intervention were 
performed in the entire study population: 32 colorectal or small bowel resections, 10 partial liver 
resections, 9 gastric surgeries, 8 esophageal resections, 5 pancreatic surgeries, and 6 hernia 
procedures. Fifty (71.4%) interventions were elective operations, and 20 (28.6%) cases were 
emergency interventions, including 16 (22.8%) patients preoperatively presenting with clinical 
signs of an ileus. According the inclusion criteria, all patients arrived in the normal ward 
postoperatively without a history of aspiration, but subsequently sustained aspiration 
pneumonia. 
 
3.1 Incidence and outcome of postoperative aspiration pneumonia 
Patients with esophageal resection, partial liver resections and pancreatic resections presented 
with an incidence of aspiration pneumonia of 6.5% (8/124), 2.0% (10/499), and 2.3% (5/221), 
respectively. For the remaining surgical procedures, the incidence of aspiration pneumonia was 
<1%. 
Aspiration pneumonia occurred on average postoperative day 7.0±10.0, in survivors on day 
6.5±9.6 and in the non-survivors on day 8.4±11.1 (p=0.595). Overall mortality was 27.1% 
(n=19). A total of 39 (55.7%) patients were admitted to the ICU after aspiration pneumonia. Of 
those, 37 (52.9%) patients had to be re-intubated, with an additional average length of 
mechanical ventilation of 4.1±4.9 days and an additional ICU length of stay of 5.7±9.5 days. 
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Non-survivors were intubated longer than the survivors (3.4±4.5 vs. 6.2±5.7 mechanical 
ventilation days, p=0.059). Total HLOS of the entire study population was 31.9±24.8 days.  
 
3.2 Risk factors for mortality 
Table 1 shows the detailed preoperative parameters obtained. A high incidence of patients with 
a history of previous surgical interventions was found (n=54, 77.1%). A history of alcohol abuse 
or smoking was present in 22 (31.3%) and 21 (30.0%) patients of the study population. 
Moreover, sixteen 16 (22.9%) patients suffered from GERD and fifteen (21.4%) patients were 
diagnosed with pre-existing chronic pulmonary disease. Patients in the non-survivor group were 
statistically significant older than the survivors (77.1±7.1 vs. 69.2±13.3 years, p=0.019). The 
remaining preoperative variables showed no statistical differences between the two groups 
(Table 1).  
The comparisons of intraoperative variables between the survivor and non-survivor group is 
presented in Table 2. Operation time and intraoperative blood loss were similar in the groups, 
however, a trend was found for a higher number of blood component transfusions (FFP and/or 
RBC) for the non-survivor group than for the survivors [31.4% vs. 57.9%, p=0.056]. The different 
surgical procedures performed were not associated with an increased risk of death. 
Interestingly, patients receiving a colostomy tended to die more often after aspiration 
pneumonia than patients without colostomy (26.3% vs. 7.8%, p=0.054). However, those 
patients who required a colostomy significantly more often had a preoperative diagnosis of ileus 
(66.7% vs. 16.4%, p=0.003), with a gastric tube more often inserted preoperatively (33.3% vs. 
4.9%, p=0.025). 
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Postoperative variables obtained are shown in Table 3. The non-survivors presented 
significantly more often with bilateral infiltrates detected in the radiological exams compared to 
the survivor group (68.4% vs. 39.2%, p=0.035). Of note, 76.0% of patients suffered from 
prolonged postoperative nausea and vomiting with re-insertion of a nasogastric tube performed 
in 41 (58.6%) patients of the entire study population (Table 3). Antiemetic drugs were 
administered in 56 (80.0%) patients. Forty patients (57.1%) received more than one sedative, 
with an overall number of 2.6±1.6 sedative drugs per patient. However, when comparing 
surviving to non-surviving patients, no statistically significant difference in the number of 
administered sedative drugs was found between survivors and non-survivors. Interestingly, 
survivors tended to be treated longer with a Patient Controlled Analgesia (PCA) system than 
non-survivors (5.5±3.9 days vs. 2.2±0.5 days, p=0.117).  
Forward logistic regression revealed older age [OR 7.41 (95% CI: 1.29-42.62)], bilateral 
aspiration pneumonia [OR 7.39 (95% CI: 1.86-29.29)] and intraoperative requirement of blood 
component transfusion [OR 5.09 (95% CI: 1.34-19.38)] as independent risk factors for mortality 
(overall R2=0.336). Variables entered into the equation included: age≥65 years, requirement for 
blood component transfusion (FFP and/or PRBC), bilateral aspiration pneumonia, at least one 
episode of MAP≤55mmHg intraoperatively, emergency surgery, preoperative insertion of gastric 
tube, preoperative ileus, type of operation (liver, colorectal, small bowel, pancreas, stomach, 
esophagus), preoperative intake of neuroleptic drugs, history of chronic pulmonary disease, and 
history of neuropsychiatric disease.  
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4. Discussion 
Despite advances in airway management, intensive care medicine and anesthesiology, the 
incidence of aspiration pneumonia has been reported and is confirmed in our study to occur in 
approximately 1% of patients undergoing abdominal surgery, resulting in a high mortality rate of 
up to 30%[1, 3]. Risk factors for fatal outcome after aspiration have not been studied so far. 
Therefore, we opted to characterize patients who suffered postoperative aspiration pneumonia 
after abdominal surgery, with an attempt to identify risk factors for fatal outcome. The 
identification of those patients at increased risk for death after aspiration may help to further 
improve patients outcome. 
In accordance with the literature, the current study population that suffered aspiration 
pneumonia comprised elderly patients with multiple co-morbidities and rather high ASA scores. 
The current analysis showed that older age is independently associated with mortality. 
Therefore, close observation and strict application of preventive measures to avoid pulmonary 
aspiration is of paramount importance in elderly patients.  
Surprisingly, preoperative ileus as well as emergency surgery had no statistically significant 
impact on the mortality of patients after aspiration pneumonia. In addition, the type of surgery 
performed did not correlate with either the incidence or the mortality of this pulmonary 
complication. Interestingly, patients undergoing esophageal resection presented with the 
highest incidence of aspiration pneumonia (6.5%), but no fatal outcome occurred in this 
subgroup. However, the limited number of patients may have resulted in non-significant results. 
Nevertheless, this observation might be explained by the fact that, after esophageal resection, 
these patients receive the maximum available monitoring during the postoperative course, due 
to the known high potential for complications after this type of surgery. 
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Interestingly, in the current study group, intraoperative administration of blood components was 
identified as an independent risk factor for mortality after pulmonary aspiration. This effect could 
be explained by the increased risk of pulmonary complications and pulmonary susceptibility to 
additional inflammatory mediators (e.g. gastric content) after transfusions of either RBC or 
FFP[9] (i.e. TRALI (Transfusion-related acute lung injury) and TACO (Transfusion-related 
circulatory overload)). TRALI is defined as the onset of respiratory distress after blood 
transfusion due to donor antibody mediated and non-antibody mediated events and has long 
been regarded as a rare complication of transfusion medicine. Today the US Food and Drug 
Administration recognizes the syndrome as the leading cause of transfusion-related 
mortality[10]. Transfusion related complications are likely to pronounce and aggravate the 
clinical course of aspiration pneumonia[11].  With the risk of TRALI or TACO in mind, as 
suggested by other investigators, we recommend a ‘patient-tailored transfusion policy’ with a 
transfusion threshold of 70 g/l or below, with a target hemoglobin range of 70–90 g/l, unless 
specific co-morbidities or acute illness-related factors modify the clinical decision making[12]. 
As expected, a high rate of re-intubation (52.9%) and ICU admission (55.7%) was observed in 
the current population. In line with the extent of aspiration pneumonia, non-survivors were 
intubated longer than survivors (6.2±5.7 vs. 3.4±4.5 days, p=0.059). Not surprisingly, the non-
survivors presented more frequently with bilateral infiltrates in the conventional radiological 
exam compared to the survivor group (68.4% vs. 39.2%, p=0.035).  
As expected, the use of gastric tubes did not influence the clinical course of patients with 
aspiration pneumonia[7]. Together with the fact that nasogastric tubes do not protect patients 
from pulmonary aspiration, we support the recommendations in the current literature to abandon 
routine nasogastric decompression tubes in elective surgical patients[7].  
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We were surprised by the frequent use of sedative drugs, with 57.1% of patients receiving more 
than one drug (2.6±1.5) with known sedative effect. It is known that sedatives have the potential 
to suppress the swallowing reflex and other reflexes, thus increasing the risk for pulmonary 
aspiration; the clinician should be aware of this potentially life-threatening side-effect[13]. 
However, according to our knowledge, no study is currently available that explicitly examines 
the impact of sedative drugs on the rate of pulmonary aspiration after abdominal surgery. 
Interestingly, the use of patient-controlled analgesia (PCA) with dose-dependent, sedative 
effects tended to be applied longer in the survivor group than to the non-survivors (5.5±3.8 vs. 
2.2±0.5 days, p=0.117).  
 
5. Conclusion 
Aspiration pneumonia is a rare complication in patients after abdominal surgery, but with a 
persistent high mortality rate. Older age, intraoperative blood component transfusion, and 
bilateral infiltrates on routine radiological examination are independent risk factors for mortality. 
After pulmonary aspiration, early identification and close monitoring and treatment of patients at 
increased risk for lethal outcome are crucial in further reducing postoperative mortality. 
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 Table 1: Comparison between survivors and non-survivors with aspiration pneumonia: 
Demographics and preoperative parameters 
 
GERD = Gastroesophageal Reflux, PPI = Proton Pump Inhibitors.  
 
 
 
 
 All (n=70) Survivors (n=51) 
Non-survivors 
(n=19) p 
Gender (male) 53 (75.7%) 37 (72.5%) 16.0 (84.2%) 0.367  
Age (years) 71.4±12.4 69.2±13.3 77.2±7.1 0.019  
Pulmonary disease 15 (21.4%) 12 (23.5%) 3 (15.8%) 0.744  
GERD 16 (22.9%) 12 (23.5%) 4 (21.1%) 1.000  
History of smoking 21 (30.0%) 18 (35.3%) 3 (15.8%) 0.148  
Alcohol abuse 22 (31.4%) 17 (33.3%) 5 (26.3%) 0.399  
Sedatives 27 (38.6%) 18 (35.3%) 9 (47.4%) 0.414  
Neuroleptic drugs 10 (14.3%) 6 (11.8%) 4 (21.1%) 0.443  
Opiates 14 (20.0%) 8 (15.7%) 6 (31.6%) 0.181  
PPI 28 (40.0%) 20 (39.2%) 8 (42.1%) 1.000  
Pre-existing neuropsychiatric 
disease  
16 (22.9%) 11 (21.6%) 5 (26.3%) 0.752 
Emergency surgery 20 (28.6%) 13 (25.5%) 7 (36.8%) 0.383  
Preoperative ileus 16 (22.8%) 9 (17.6%) 7 (36.8%) 0.114  
Preop. gastric tube 6 (8.6%) 3 (5.9%) 3 (15.8%) 0.334 
History of previous surgery:     
- total 54 (77.1%) 40 (78.4%) 14 (73.7) 0.752  
- abdominal 45 (64.3%) 32 (62.6%) 13 (68.3%) 0.782 
- cardiovascular 22 (31.3%) 18 (35.3%) 4 (21.1%) 0.386 
- thoracic 5 (7.1%) 4 (7.7%) 1 (5.3%) 1.000 
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Table 2: Comparison between survivors and non-survivors with aspiration pneumonia: Type of 
surgery and intraoperative parameters 
 
All (n=70) Survivors (n=51) 
Non-survivors 
(n=19) p 
Surgery performed:     
- large bowel 20(28.6%) 14 (27.5%) 6 (31.6%) 0.771  
- small bowel 12 (17.1%) 9 (17.6%) 3 (15.8%) 1.000  
- hepatobiliary 10 (14.3%) 6 (11.8%) 4 (21.1%) 0.265  
- gastric 9 (12.9%) 6 (11.8%) 3 (15.8%) 0.696  
- esophageal resection 8 (11.4%) 8 (15.7%) 0 0.097 
- hernia repair 6 (8.6%) 4 (7.8%) 2 (10.5%) 0.660  
- pancreatic 5 (7.1%) 4 (7.8%) 1 (5.3%) 1.000  
     
Ileostomy 8 (11.4%) 5 (9.8%) 3 (15.8%) 0.674  
Colostomy 9 (12.9%) 4 (7.8%) 5 (26.3%) 0.054  
Bloodloss (mL) 716±893 801±999 486±461 0.371 
OR time (min) 260±140 277±149 213±107 0.132 
Blood component transfusion 
(PRBC and/or FFP) 27 (38.8%) 16 (31.4%) 11 (57.9%) 0.056 
     
Respiratory failure 2 (2.9%) 2 (3.9%) 0 1.000  
ASA Score 3.06 ± 
0.634 
3.08±0.627 3.00±0.667 0.651 
     
Intraoperative hypotension  59 (84.3%) 43 (84.3%) 16 (84.2%) 1.000 
Intraoperative hypotension (min) 49.1± 49.9 51.1±50.5 43.9±49.4 0.671 
 
ASA Score = American Society of Anesthesiology Score, FFP = Fresh Frozen Plasma, PRBC = 
Packed Red Blood Cells 
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Table 3: Comparison between survivors and non-survivors with aspiration pneumonia: 
Postoperative parameters 
 All (n=70) Survivors (n=51) Non-survivors (n=19) p 
Aspiration postop. day 7.0±10.0 6.5±9.6 8.4±11.1 0.595 
Bilateral aspiration 
pneumonia on 
radiological exam 
32 (45.7%) 19 (37.3%) 13 (68.4%) 0.030 
IMC to ICU readmission 39 (55.7%) 26 (51.0%) 13 (68.4%) 0.280 
IMC to ICU day 8.5±10.5 9.9±12.4 5.8±4.1 0.219 
Total ICU (days) 5.7± 9.5 5.4± 9.7 6.4± 8.9 0.506 
     
Re-intubation 37 (52.9%) 27 (52.9%) 10 (52.6%) 1.000 
Additional mechanical 
ventilation [n (days)] 53 (4.1 ± 4.9) 40 (3.4±4.5) 13 (6.2±5. 7) 0.059 
Respiratory failure 24 (34.3%) 16 (31.4%) 8 (42.1%) 0.412 
PCA 22 (31.4%) 17 (33.3%) 5 (26.3%) 0.773 
PCA days 4.7±3.7) 5.5±3.9) 2.2±0.5) 0.117 
PDA 37 (52.9%) 28 (54.9%) 9 (48.4%) 0.601 
PDA days 4.9±2.6 4.7±2.1 5.4±3.9 0.900 
Prokinetic agents 16 (22.9%) 12 (23.5%) 4 (21.1%) 1.000 
Antiemetics 56 (80.0%) 43 (84.3%) 13 (68.4%) 0.181 
Opiates 64 (91.4%) 46 (90.2%) 18 (94.7%) 1.000 
Neuroleptic drugs 34 (48.6%) 22 (43.1%) 12 (63.2%) 0.181 
# of Sedatives  60 (2.58±1.63) 46 (2.59±1.62) 14 (2.57±1.69) 0.993 
     
PPI  66 (94.3%) 47 (92.2%) 19 (100%) 0.568 
     
Gastric tube 40 (57.1%) 27 (52.9%) 13 (68.4%) 0.287 
Gastric tube reinsertion 41 (58.6%) 29 (56.9%) 12 (63.2%) 0.786 
Gastric tube 
postoperative (days) 9. 8±14.0 11.3±16.2 6.5±7.4 0.117 
     
Enteral feeding tube 31 (44.3%) 24 (47.1%) 7 (36.8%) 0.590 
Nausea 53 (75.7%) 41 (80.4%) 12 (63.2%) 0.208 
Vomiting 55 (78.6%) 43 (84.3%) 12 (63.2%) 0.098 
Vomiting  (day) 9.3±16.0) 9.1±16.8 9.8±12.9 0.473 
First bowel movement 
(day) 4.4±3.5 4.7±3.6 3. 6±3.4 0.145 
First mobilization from 
bed (day) 1.9±2.4 1. 8±2.0 2.1±3.2 0.409 
Known psychiatric/ 
neurologic disease 16 (22.9%) 11 (21.6%) 5 (26.3%) 0.752 
 
IMC = Intermediate Care, ICU = Intensive Care Unit, PCA = Patient Controlled Analgesia, PDA 
= Peridural Anesthesia, PPI = Proton Pump Inhibitors.  
